T horacic aortic aneurysm and dissection (TAAD) and the related aortic rupture are highly lethal vascular conditions. Although TAAD is considered the terminal process in thoracic aortic aneurysm (TAA) expansion, TAA does not develop into TAAD in many patients. 1 The pathogenesis of TAAD is also distinct from TAA. Hypertension represents a major risk factor for TAAD, with 70% to 85% of TAAD victims having hypertension. 2 In patients with TAAD, angiotensin II (AngII) levels are relatively elevated.
blockers reduced the levels of both p-SMAD2 (phosphorylated mothers against decapentaplegic homolog 3) and p-ERK (phosphorylated extracellular regulated protein kinases) in the medial layer and prevented dissection progression. 10 However, in a recent study, treatment with a monoclonal TGF-β-neutralizing antibody failed to achieve any therapeutic effects in a widely used mouse model of hyperactive TGF-β signaling-induced aneurysm and dissection. 10, 11 A clinical study by Lacro et al 12 showed that AngII type I receptor blockers were not better than β-blockers in terms of therapeutic efficacy. Precise roles of AngII and TGF-β signaling in the pathogenesis of TAAD remain unknown.
In the present study, we examined whether AngII could induce TAAD in Smad3 mutant mice. Because microRNA-21 (miR-21) has been identified as a regulator of MAPK (mitogen-activated protein kinase) pathways in cancer cells, 13 we investigated whether miR-21 exerts a therapeutic effect on AngII-induced TAAD in Smad3 mutant mice.
Materials and Methods

Animal Care and AngII Infusion
Smad3
−/− mice have been characterized previously, 14 ) littermates were used as control animals throughout the study. C57BL/6 mice were purchased from HFK Bioscience (Beijing, China). The recent ATVB Council Statement suggests to consider sex differences in aneurysm studies, including TAAD. 15 We only studied male mice because male mice at 6 to 8 weeks of age could tolerate the surgery to implantation mini pumps better and had less sex hormone variations. 15 All mice used in the experiments were 6-to 8-week-old males (body weight of 18-25 g). AngII (Sigma, Chemical Co; #A-9295) was administered via Alzet osmotic 2004 mini pumps (ALZAT Scientific Products) at a dose of 1000 ng/min per kilogram, which was based on doses reported in previous studies by Daugherty et al. 16 Mice were infused with 5.6 mg/kg per day norepinephrine (Sigma, Chemical Co; no. A-7256). SP600125 (Sigma, Chemical Co; no. S-5567) was infused through mini pumps at a dose of 30 mg/kg per day to inhibit JNK (c-Jun N-terminal kinase) in the mouse model. Mice were anesthetized with sodium pentobarbital, and pumps were placed via subcutaneous retroarticular incisions.
All animal experiments were performed in a specific pathogenfree barrier facility in accordance with the institutional guidelines and an approved protocol (IORG no: IORG0003571) from Tongji Medical College, Huazhong University of Science and Technology.
Echocardiography
Ultrasonic cardiograms were obtained using the Vevo 2100 Microimaging System with a 30-MHz transducer (VisualSonics, Inc, Canada). Images of the ascending aorta were captured from a parasternal long-axis view of the section as reported previously. 17 Shortand long-axis scans of the abdominal aorta were performed from the level of the left renal arterial branch to the suprarenal region. The measurements were performed 3× in each mouse, and the investigator was blind to the experimental groups.
Blood Pressure Measurements
Systolic blood pressure was measured using a tail-cuff method (Kent Scientific Corporation). The tail was constrained using a tail cuff. Sensors were used to indirectly record the blood pressure. This indirect method has some limitations in monitoring the mean blood pressure. 18 Thus, in our study, we only reported systolic blood pressure in different groups. Systolic blood pressure was measured at least 3× in each mouse at 0, 7, 14, and 28 days.
Histological Examination
Mice were anesthetized, and the aortas, hearts, spleens, and other organs were harvested at each time point. After flush-cleaning with heparin, samples were fixed with 4% paraformaldehyde for histology or frozen in liquid nitrogen for molecular biology. The tissue was embedded in paraffin and sectioned at a thickness of 5 μm. Hematoxylin and eosin (HE) and Verhoeff's Van Gieson staining was performed using standard techniques. For immunohistochemistry, aortic sections were mounted on poly-l-lysine-coated microscope slides, and antigens were retrieved through the application of citric acid for 3 minutes at 121°C. The sections were incubated with primary antibodies against p-SMAD2 (no. 3108, 1:200), p-ERK1/2 (no. 4370, 1:200), and p-JNK (phosphorylated c-Jun N-terminal kinase; no. 4668, 1:150) from Cell Signaling Technology (MA), αSMA (alpha-smooth muscle actin; ab5694, 1:200), CCL2 (C-C motif chemokine ligand 2; ab25124, 1:100), and vimentin (ab8978, 1:200) from Abcam, SMAD7 (no, MAB2029, 1:50) and MMP9 (matrix metalloprotein 9; no. AF909, 1:100) from R&D Systems (MN), p65 (no. 10745-1-AP, 1:50) from Proteintech Group Inc (China) or an isotype-matched, irrelevant IgG (no. 3900, 1:200) from Cell Signaling Technology (MA). After a 12-hour incubation at 4°C, the sections were incubated with secondary antibodies (Thermo Fisher Scientific) and detected using the diaminobenzidine kit (Thermo Fisher Scientific). The number of positive cells was averaged from 3 high-power fields.
In Situ Hybridization
In situ hybridization was used to detect miR-21 expression using a previously reported technique. 19 Diethylpyrocarbonate was added to 4% paraformaldehyde to inhibit endogenous and exogenous RNAses. Tissue sections were incubated with a proteinase K solution for 20 minutes at 37°C. Prehybridized sections were covered with hybridization buffer for 2 hours at the hybridization temperature. The sections were denatured at 90°C for 4 minutes and then directly incubated with microRNA probes or scrambled sequences (Exiqon, Denmark) overnight at the hybridization temperature. The slides were washed in a decreasing concentration gradient of saline-sodium citrate and then treated with blocking buffer for 1 hour at room temperature. Diluted alkaline phosphatase-conjugated antidigoxigenin (Roche, Switzerland) and anti-αSMA antibodies were added to the tissue sections overnight at 4°C. A fluorescence microscope was used to examine the labeling on day 3. Images were processed using Image-Pro Plus 6.0.
Real-Time PCR
Tissue samples and cultured cells were processed for RNA extraction using the TRIzol reagent (Life Technologies), and the RNA was quantified using a Nanodrop spectrophotometer. Reverse transcription was performed with the TaqMan MicroRNA reverse transcription kit (Life Technologies) using random primers and the mRNA samples. Realtime (RT)-PCR was performed using cDNA samples and the primers listed in Table I 
Primary Aortic VSMC Cultures
Ascending thoracic aortas were harvested from 6-month-old male mice. The adventitia was removed under a microscope. The aortic wall was cut into small pieces, and collagenase type II (Worthington Biochemical Corporation) was applied to digest the tissue at 37°C for 1 hour. The digestion was stopped by the addition of BSA. Cells were resuspended and cultured in 20% BSA containing DMEM (all from Gibco). Cells were serially expanded and used at passages 3 to 6 for the experiments. Cells were subjected to 24 hours of serum starvation before evaluation of the signaling pathways. The Cell Counting Kit 8 (Dojindo Molecular Technology, Japan; no. CK04) was used for the analysis of cell proliferation in vitro. Cells were cultured in 96-well plates at a density of 1×10 4 cells per well. Then, AngII (1 μmol/L) was added, and cells were stimulated with the Cell Counting Kit 8 reagent for 4 hours. A microplate reader was used to measure the absorbance at 450 nm. 
BM Cell Transplantation
In Vitro and In Vivo Transfection
For the in vitro experiments, antagomiR-21, agomiR-21, and control oligonucleotides (GenePharma Co, China) were transfected into VSMCs. The transfection mixture consisted of serum-free medium plus Lipofectamine 2000 (Invitrogen). After 12 hours, the transfection medium was replaced with complete medium. RT-PCR was performed after 48 hours to verify the transfection efficiency. For the in vivo studies, the antagomiR-21, agomiR-21, and control oligonucleotide dosage was 10 mg/kg, which was based on previous studies conducted by Maegdefessel et al. 20 Tail vein injections were performed once per week for 4 weeks.
Lentiviral vector (LV)-Smad7-RNAi (GeneChem, China) was used to silence the mouse Smad7 gene; a nontargeting siRNA (small interfering RNA) was used as a control. Briefly, cells were transfected with a final concentration of 1×10 6 transducing units LV-Smad7-RNAi using serum-free medium and transfection reagent. After 6 hours, the medium was replaced with fresh medium, and the cells were cultured for 48 hours. The transfection efficiency was determined by the microscopic observation of GFP (green fluorescent protein) and RNA, or proteins were extracted from the cells for follow-up experiments. For the in vivo rescue experiment, LV-Smad7-RNAi or LV-scramble was dissolved in 300 μL of saline at a dose of 7.6×10 7 infection-forming units per mouse and injected via the tail vein on the day of AngII infusion.
Statistical Analyses
The data are expressed as the means±SD. All data were analyzed using Prism 5.0 software (GraphPad Software, CA) and examined for satisfaction of equal variance and normality test assumptions. Comparisons between 2 groups were performed using 2-tailed Student t test, and comparisons between multiple groups were performed using 1-way ANOVA with Bonferroni post hoc test. The survival curve was plotted using the Kaplan-Meier method, and differences were determined using the log-rank test. P<0.05 was considered statistically significant.
Results
AngII Infusion in Smad3 Mutant Mice Led to Accelerated Ascending Aortic Aneurysm But Not Dissection
We used Smad3 +/− heterozygous mice to characterize the effects of TGF-β signaling in combination with AngII infusion. During a 28-day period of AngII infusion, we did not observe any differences in survival between the groups ( Figure 1A ). The ascending aorta in the mice was ultrasonographically measured. The luminal diameter of the ascending aorta was significantly greater in the Smad3 We subsequently examined the effects of AngII infusion on signaling pathways in Smad3 +/− mice ( Figure 1D and 1E). Protein lysates were collected from the ascending aorta after AngII infusion for 28 days. As predicted, both ERK and JNK phosphorylation were increased by AngII. Phosphorylation of the canonical TGF-β signaling protein SMAD2 was also increased after AngII administration. After phosphorylation of the MAPK pathway upstream kinase MEK1/2, AngII infusion led to ERK and JNK phosphorylation. Smad3 +/− mice tended to have higher levels of phosphorylated JNK and SMAD2, possibly because of partial dysfunction in the SMAD3 protein, leading to canonical and noncanonical TGF-β signaling dysfunction associated with JNK overactivation. We also detected TGF-β signal-related genes ( Figure 
miR-21 Expression Was Elevated in the Aorta of AngII-Infused Smad3 +/− Mice
MicroRNA-21 has been shown to regulate ERK and JNK phosphorylation. 13 The AngII-infused Smad3 +/− mice developed aortic aneurysm and exhibited elevated p-ERK and p-JNK expression. Unlike norepinephrine, AngII was associated with increased ERK and JNK phosphorylation. SMAD proteins also control miR-21 maturation. 23 A positive feedback loop between +AngII, n=9; log-rank test). B, The luminal diameter of the ascending aorta was echocardiographically measured (n=8/group). C, Ultrasound echocardiographic (UCG) images (top) and hematoxylin and eosin (HE)-stained sections (bottom) showing expansion of the aortic diameter and wall remodeling in lesions (n=6-8/group). D and E, Western blotting for p-ERK (phosphorylated extracellular regulated protein kinases), p-JNK (phosphorylated c-Jun N-terminal kinase), p-MEK1/2 (phosphorylated mitogen-activated protein kinase kinase), and p-SMAD2 expression in the ascending aorta 28 d after saline or AngII infusion. A 2-tailed Student t test was used for comparisons between 2 groups, and the log-rank test was used for the evaluation of Kaplan-Meier survival curves. The data are presented as the means±SDs for each group. *P<0.05. Scale bars, 1 mm. Original magnification: ×100. ns indicates nonsignificance. p-SMAD2/3 and miR-21 expression has been observed in patients with prostate cancer. 24 The expression of miR-21 in the dilated ascending aorta warrants confirmation. We detected miR-21 expression in aortic aneurysm where ERK and JNK phosphorylation was elevated. After AngII infusion, miR-21 expression was upregulated in Smad3 +/− mice compared with animals of the same genotype that had not received AngII infusion. In contrast, before AngII infusion, miR-21 levels were decreased in Smad3 +/− mice (Figure 2A) , and miR-21 levels gradually increased as the condition deteriorated ( Figure 2B ). In situ hybridization was used to detect miR-21 expression in Smad3 mutant mice that had received AngII infusion. In the merged image, yellow color indicates the colocalization of red (αSMA) and green (miR-21) labeling, indicating that miR-21 expression was upregulated in the αSMA + medial region ( Figure 2C ). Given the association between the MAPK pathway and miR-21, we hypothesized that miR-21 overexpression was associated with aneurysm development, but its roles remain unknown.
Then, antagomiR-21 and oligonucleotides with a scrambled sequence were injected into 6-week-old Smad3 +/− mice via the tail vein. The effects of the oligonucleotides were detected by RT-PCR 7 and 14 days after injection ( Figure IV in the onlineonly Data Supplement). The luminal diameter was measured 14 days during AngII infusion ( Figure 2D and 2F). Ultrasonic imaging revealed aortic expansion after antagomiR-21 treatment. After agomiR-21 administration, a protective effect was observed in these animals compared with the animals that had received the scrambled control. Consistent with the degree of aortic expansion, HE staining of the biopsied tissues after antagomiR-21 administration revealed obvious lesions 14 days during AngII infusion ( Figure 2E ). This result supports the hypothesis that artificial inhibition of miR-21 aggravates the expansion of aortic aneurysms. Western blotting showed that activation of the ERK and JNK phosphorylation by AngII was suppressed after antagomiR-21 injection into the ascending aorta ( Figure 2G and 2H ). In addition, the activation of p-SMAD2 and its downstream target PAI-1 was significantly promoted in antagomiR-21-injected mice ( Figure 2G and 2H) . Several studies have shown that inhibition of ERK or JNK activation could ameliorate ascending aortic aneurysms. 8, 21 In the present study, inhibition of the ERK and JNK pathways together with p-SMAD2 downregulation exacerbated the luminal dilation of the aneurysm in the ascending aorta.
Aneurysm and Dissection Were Exacerbated in AngII-Infused Double Knockout Mice
We subsequently generated Smad3 +/− and miR-21 −/− double knockout mice to investigate whether complete knockout of miR-21 in AngII-infused Smad3 mutant mice would aggravate the severity of the conditions. Surprisingly, all Smad3 Figure 3C ). We did not find any dilation or the formation of any aneurysm in the descending and abdominal aorta although incidence of abdominal aortic aneurysm was high in AngII-infused Apoe −/− mice. 25 In addition, miR-21 −/− mice with or without AngII infusion did not present any aneurysmal lesions or changes in the luminal diameter ( Figure  VA in the online-only Data Supplement). Histopathologic examination revealed aneurysm development, aortic thickening, loss of medial VSMCs, and inflammatory infiltration in the adventitia of the ascending aorta. Fourteen days during AngII infusion, HE staining revealed dissection formation with a separated intima floating in the vessel lumen ( Figure 3D ). In addition, Verhoeff's Van Gieson staining revealed elastin disarray and degradation in the diseased region ( Figure 3D group. No significant differences in the p-ERK levels were found between the 2 groups ( Figure 4A ). Previous studies demonstrated that the JNK pathway was involved in aneurysm formation. 26 We treated S3
−/− mice with SP600125 but found that it did not exert any effects on survival or pathology ( Figure VII in the online-only Data Supplement). We isolated primary mouse aortic VSMCs and cultured them in vitro using previously described methods 10 to assess the signal changes in VSMCs from S3
mice. Combined with the in vitro results, VSMCs did not show high p-JNK expression levels ( Figure 4B and 4C) . We speculated that the p-JNK upregulation might be the result of mechanical stretching after arterial dilation. 27 Western blotting revealed that TGF-β signal transduction pathway activity, particularly the activities of pathways involving SMAD2 and canonical TGF-β signaling, was reduced in VSMCs from S3 
−/− Mouse VSMCs Tended to Switch Phenotypes After AngII Infusion
Recent studies have shown that the upregulated TGF-β signaling in aortic aneurysms attributed to Marfan syndrome led to changes in the VSMC phenotype in the dilated zone of the aorta. 28 In our S3 +/−
21
−/− mouse model, TGF-β signaling was downregulated in VSMCs, particularly in p-SMAD2-mediated canonical TGF-β signaling ( Figure 4A and 4B) . We hypothesized that the VSMC phenotypes switched in response to the downregulation of TGF-β signaling. Immunostaining and RT-PCR analyses showed that the levels of αSMA, a phenotypic marker of VSMC differentiation, were decreased in the lesioned tunica media ( Figure 5A and 5B). In addition, RT-PCR revealed that the expression of the contractile genes αSma, Sm22, and Sm-mhc was downregulated in primarily cultured VSMCs stimulated with AngII ( Figure 5C ). The expression of the contractile genes αSma, Sm22, and Sm-mhc was also decreased in primarily cultured Smad3 +/− VSMCs transfected with antagomiR-21. In contrast, the expression of these contractile genes was increased on agomiR-21 treatment ( Figure VIII in the online-only Data Supplement). Cell Counting Kit 8 analysis, cyclin D1, and Ki-67 staining revealed excessive proliferation in vitro and in vivo ( Figure 5D , 5E, and 5I). In addition, caspase-3 was elevated in S3
−/− mice ( Figure 5F and 5H). MiR-21 knockout inhibited fibrogenesis, 29 and fibrogenesis plays an important role in aneurysmal disease. 30 However, in our mouse model, immunofluorescence staining did not reveal significant changes in the number of fibroblasts (VIMENTIN; Figure IX in the online-only Data Supplement).
MMP9 is a marker of the VSMC phenotype switch, and a previous study showed that it plays an important role in aneurysm formation. Immunofluorescence staining showed MMP9 expression in inflammatory cells from the adventitia and VSMCs after AngII infusion ( Figure 5J ). Of note, MMP9 was highly expressed in VSMCs from S3 
Discussion
VSMC phenotypes have been shown to contribute to aneurysm formation and dissection. Mutations in contraction-related genes, such as MYH11 and ACTA2, can cause aneurysm and dissection in patients. 35 The tolerance of the ascending thoracic aorta to blood pressure is based on the contractile function of VSMCs, which depends on the function of contractile proteins. 36 Mice carrying Myh11 and Acta2 mutations also develop vasculopathy because of VSMC dysfunction. 37, 38 Moreover, abnormal TGF-β signaling induces VSMC phenotype switching, which is also implicated in aneurysm development and dissection in humans and mice. In patients with Marfan syndrome, VSMCs exhibit a contractile phenotype because of enhanced TGF-β signaling, which leads to vascular , n=4; log-rank test). B, Immunohistochemistry staining for CCL2 (C-C motif chemokine ligand 2) and p65 in the thoracic aortic aneurysm (TAA) model lesions 7 or 14 d after AngII infusion (n=5-8/group). C, Real-time polymerase chain reaction (RT-PCR) showed the expression of vascular smooth muscle cell (VSMC) phenotype switching-related chemokines (Ccl2, Cxcl12, Cx3cl1, and Il-6) in the lesions of TAA models 7 d after AngII infusion (n=6/group). D, RT-PCR revealed the expression of VSMC phenotype switching-related chemokines (Ccl2, Cxcl12, Cx3cl1, and Il-6) after AngII treatment in vitro (n=8/group). E, RT-PCR showed the expression of VSMC phenotype switching-related chemokines (Ccl2, Cxcl12, Cx3cl1, and Il-6) after agomiR-21 or antagomiR-21 administration plus AngII treatment in vitro (n=8/group). F, The effects of the NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) pathway inhibitor BAY-11-7082 (BAY) plus AngII on the expression of inflammatory genes (Ccl2 and Il-6) were investigated by RT-PCR after 24-h culture (n=8/group). A 2-tailed Student t test was used for comparisons between 2 groups, and the log-rank test was used for the assessment of the Kaplan-Meier survival curve. The data are presented as the means±SDs for each group. *P<0.05 and **P<0.01. Scale bars: 40 μm (×400). ns indicates nonsignificance. stiffness. 28 In contrast, in the presence of Tgfbr2 mutations, TGF-β1 fails to induce the expression of contractile genes in VSMCs, and this failure may also lead to TAAD despite VSMC proliferation. 39 The infusion of porcine pancreatic elastase into a TAAD rats model results in decreased expression of contractile proteins and increased proteinase synthesis in VSMCs. 40 This study showed that the expression of the VSMC phenotype marker αSMA was downregulated in the lesion area before other pathological changes, such as inflammatory infiltration and dissection formation. Moreover, after VSMC dedifferentiation, VSMC phenotype switching induced NF-κB activation and chemokine expression. This result was coincident with a previous finding that Sm22 knockdown caused phenotype switching, thereby leading to inflammation and upregulation of NF-κB pathways in VSMCs. 34 Hautmann et al 41 also found that TGF-β signaling acted on CArG elements and promoted α-actin expression in VSMCs. Multiple factors contribute to VSMC phenotype switching, particularly in systemic aneurysmal disease. [42] [43] [44] In our S3
+/− 21 −/− mouse model, alterations in TGF-β signaling, miR-21 defects, and infusion with AngII exacerbated aneurysmal formation.
miR-21 expression was found to be elevated in our TAAD mouse model. These results were consistent with published data in ascending TAA specimens from patients. 45, 46 Because miR-21 overexpression has been shown to result in the excessive activation of p-JNK and p-ERK, 13 we attempted to inhibit miR-21 expression to prevent AngII-induced aneurysm development. Surprisingly, S3 +/− 21 −/− mice exhibited an unusually high mortality rate at early time after AngII infusion. Pathological examinations revealed excessive degradation and breakdown of elastic lamella 7 days during AngII infusion. Moreover, we found that the expression of SMAD7, a regulatory molecule involved in TGF-β signaling, was upregulated in S3
−/− mice. When SMAD7 was upregulated and heterozygous Smad3 was lost, canonical TGF-β signaling was oversuppressed. Moreover, SMAD7 was further upregulated after AngII infusion in our study and as reported in Liu et al's 47 study. We then used a lentivirus to silence Smad7 in vivo, which successfully prevented aneurysm and dissection in S3 +/−
21
−/− mice. These results are consistent with the concept that TGF-β signaling plays a vital role in maintaining the integrity of the aortic wall. Moreover, Spin et al 48 reported that the TGF-β/BMP (bone morphogenetic protein) pathway was downregulated in ruptured aneurysm. In addition, miR-21 responded to BMP signaling, which controlled VSMC phenotype switching 49, 50 and regulated VSMC differentiation in patients with pulmonary arterial hypertension. 51 TGF-β signaling and miR-21 synergistically promote the endothelial-tomesenchymal transition. 52 Overexpression of miR-21 enhanced the TGF-β-induced endothelial-to-mesenchymal transition in patients with diabetic nephropathy. 53 The inhibition of Smad7 using the siRNA lentivirus vector mimicked the effects of elevated miR-21 expression and led to an increase in αSMA expression in tubular epithelial cells. In addition, the miR-21 target gene Pdcd4 has been shown to play an essential role in VSMC apoptosis and proliferation. 54 So, we assume that high expression of PDCD4 might lead to VSMC apoptosis. But in miR-21 −/− mice, although PDCD4 was overexpressed, no aneurysms developed after AngII infusion. This phenomenon needs to be further studied by using S3
−/− mice with siPDCD4 or PDCD4 knockout. Diminished VSMC proliferation resulted in an increase in the size of abdominal aortic aneurysm induced by nicotine. 20 In our study, miR-21 exerted protective effects on VSMCs even though its elevation was markedly lower, which means that it could not provide sufficient protection. Using agomiR-21 to boost miR-21 reduces aneurysm. We also used an analogous treatment that artificially downregulated miR-21 expression and exacerbated TAAD. AngII has been shown to play a dual role in VSMC phenotype switching during differentiation. 42, 55, 56 In this study, AngII treatment induced rapid VSMC phenotype switching both in vivo and in vitro. Therefore, the aforementioned factors involved in our hybrid model pathologically contribute to the development of TAAD (Figure 8 ).
In the AngII infusion model, inflammatory infiltration is significant during aneurysm development and dissection. AngII-induced aneurysms are usually located on the abdominal aorta in hypercholesterolemic mice. 25, 57 AngII infusion in C57 mice was recently shown to induce the development of ascending aortic aneurysms. 58 Aneurysms in our S3 +/−
−/− mice were more severe and showed faster progression. According to a study by Tan et al, 59 the Smad3 −/− mouse model also developed TAA and abdominal aortic aneurysm after AngII infusion, and the aneurysms were curable by macrophage depletion. Adventitial leukocyte accumulation occurs in inflammation-elicited aneurysms, and aneurysmal changes are concomitant with the inflammatory response. In our S3
−/− mice, VSMC phenotype switching preceded massive accumulation of inflammatory cells. Thus, the expression of chemokines in VSMCs might underlie inflammatory cell infiltration. BM cell transplantation revealed that inflammatory infiltration was not a dictating factor in TAAD formation. In fact, the absence of miR-21 inhibits inflammation by reducing Th17 cell polarization. 60 However, overexpression of miR-21 was recently demonstrated to exert inhibitory effects on macrophages. 61 In general, the lopsided inhibition of the canonical TGF-β signaling pathway might upregulate the noncanonical TGF-β signaling pathway and lead to uncontrollable inflammation. Deficiency in miR-21 can decrease the AngII-induced activation of the MAPK pathway. However, no available evidence indicates that inflammation is the primary cause of aneurysmal formation in S3 
−/− mice infected with lentiviruses 14 d after AngII infusion (n=5-6/group). A 2-tailed Student t test was used for comparisons between 2 groups, and the log-rank test was used for the evaluation of the Kaplan-Meier survival curve. The data are presented as the means±SDs for each group. *P<0.05 and **P<0.01. Scale bars: 1 mm (×100) and 100 μm (×200). ns indicates nonsignificance.
inflammatory infiltration might be secondary to the development of aneurysms and dissection in the TAAD model.
Multiple studies have shown that Smad3 gene expression plays a pivotal role in aneurysm development and dissection. 17, 59, 62 These studies focused on inflammation after the disruption of TGF-β signaling. One of our previous studies showed that Smad3 −/− mice spontaneously developed inflammationassociated aneurysms in the ascending aorta at 8 months of age. 17 Tan et al 59 also described inflammatory aortic aneurysms in AngII-infused Smad3 −/− mice. These findings differ from those observed in patients with a SMAD3 mutation, in which the development of ascending aortic aneurysms and dissection was gradual. [63] [64] [65] According to these studies, noncanonical TGF-β signaling is intimately associated with aneurysm and dissection formation. Some researchers used AT1 (angiotensin II receptor type 1) receptor antagonists or its specific inhibitors to inhibit p-ERK and p-JNK. 10, 21 Using a TGF-β-neutralizing monoclonal antibody, some studies showed that the therapeutic effects are poor or uncertain and mainly dependent on the age of the treated subjects.
11 TGF-β-neutralizing antibody treatment showed that AngII-induced aortic ruptures are associated with serum TGF-β concentrations and the treatment duration. 66 A retrospective study by Franken et al 67 showed that the serum TGF-β levels are decreased in Marfan syndrome patients after receiving Losartan, and the aortic root dilatation rate was higher in the ensuing 3 years. Elevated TGF-β levels might be related to negative feedback caused by fibrillin-1 haploinsufficiency. TGF-β participates in the repair of vascular walls during vascular remodeling. 68 In this study, miR-21 deficiency also downregulated canonical TGF-β signaling. This effect was similar to the early attenuation of TGF-β signaling on treatment with a neutralizing antibody, indicating that the VSMC phenotype switching induced by downregulated TGF-β signaling might lead to aneurysm formation and dissection. 69 A variety of cells are implicated in aneurysmal formation. Our research ruled out the involvement of BM-derived cells in the initial pathogenesis processes. The expression of miR-21 in the cellular components of the vessel walls, including endothelial cells and fibroblasts, has been shown to be involved in the angiopathy of other diseases. Endothelial miR-21 deficiency affects the function of vascular elastin. 70 Knockdown of miR-21 attenuated the activation of fibroblasts in idiopathic pulmonary fibrosis. 71 However, in this study and a study by Maegdefessel et al, 20 fibrosis remained unchanged regardless of whether miR-21 was down regulated or upregulated. Hence, we were led to assume that fibrosis was not a major pathogenic factor in our aneurysm model. Although our in situ hybridization results showed that S3 +/−
−/− mice initially experienced pathological changes in their VSMCs, there was no direct evidence showing that miR-21 works on the vessel median layer. In view of these limitations, further studies will require the use of tissue-specific Smad3 +/− knockout mice. In addition, the postnatal knockdown of miR-21 using conditional knockout mice may generate more stable and definite effects than antagomiR-21 treatment.
In conclusion, our study showed that miR-21 deficiency in combination with Smad3 haploinsufficiency could inhibit TGF-β signaling. VSMCs underwent phenotype switching, particularly in response to AngII infusion, resulting in a loss of contractile functions and a deterioration in inflammation at the lesion site, which subsequently promoted aneurysm development and dissection. Thus, TGF-β signaling inactivation should be considered in the search for novel therapeutic treatments. 
